A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
Open Access
- 15 March 2017
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 163 (2) , 241-254
Abstract
Background “Precision medicine” is a concept that by utilizing modern molecular diagnostics, an effective therapy is accurately applied for each cancer patient to improve their survival rates. The treatment of triple-negative breast cancer (TNBC) remains a challenging issue. The aim of this study was to compare the molecular subtypes of triple-negative breast cancer (TNBC) between Taiwanese and Non-Asian women. Methods GEO Datasets for non-Asian (12 groups, n = 1450) and Taiwanese (3 groups, n = 465) breast cancer, including 617 TNBC, were acquired, normalized and cluster analyzed. Then, using TNBC cell lines of different subtypes, namely, MDA-MB-468 (basal-like1, BL1), MDA-MB-231 (mesenchymal stem like, MSL), BT-549 (mesenchymal, M), MDA-MB-453 (luminal androgen receptor, LAR), and DU4475 (immunomodulatory, IM), real-time PCR in triplicate for 47 genes signatures were performed to validate the specificity of these subtypes. Results The results showed that the percentage of TNBC subtypes in non-Asian women, namely, BL1, BL2, IM, M, MSL, and LAR was 13.56, 8.91, 16.80, 20.45, 8.30, and 11.13%, respectively. When data from Taiwanese were normalized and clustered, five TNBC subtypes, namely, BL (8.94%), IM (13.82%), M (22.76%), MSL (30.89%), and LAR (23.58%), were classified. Real-time PCR validated the specificity of these subtypes. Besides, the presence of interaction between IM- and MSL-subtypes suggests the involvement of tumor microenvironment in TNBC subtype classification. Conclusion Our data suggested that there exist different presentations between non-Asian and Taiwanese TNBC subtypes, which provides important information when selection of therapeutic targets or designs for clinical trials for TNBC patients.Keywords
Funding Information
- Ministry of Health and Welfare (TW) (MOHW104-TDU-B-211-124-001)
- Ministry of Health and Welfare (MOHW105-TDU-B-211-134003, MOHW-103-TDU-212-114002)
- Taipei Veterans General Hospital (V106C-029)
This publication has 44 references indexed in Scilit:
- Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTENPLOS ONE, 2013
- An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast CancerCancer Informatics, 2013
- Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast CarcinomasPLOS ONE, 2012
- Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profilesBreast Cancer Research, 2011
- Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in TaiwanPLOS ONE, 2011
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal WomenClinical Cancer Research, 2011
- Triple‐negative breast cancer: Present challenges and new perspectivesMolecular Oncology, 2010
- Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GABreast Cancer Research and Treatment, 2008
- Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networksBioinformatics, 2007